0001439222-22-000051.txt : 20220524
0001439222-22-000051.hdr.sgml : 20220524
20220524161149
ACCESSION NUMBER: 0001439222-22-000051
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220520
FILED AS OF DATE: 20220524
DATE AS OF CHANGE: 20220524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schenkein David P
CENTRAL INDEX KEY: 0001578200
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 22956758
MAIL ADDRESS:
STREET 1: C/O BLUEBIRD BIO, INC.
STREET 2: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001439222
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-8600
MAIL ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AGIOS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20080703
4
1
wf-form4_165342307618924.xml
FORM 4
X0306
4
2022-05-20
0
0001439222
AGIOS PHARMACEUTICALS, INC.
AGIO
0001578200
Schenkein David P
C/O AGIOS PHARMACEUTICALS, INC.
88 SIDNEY STREET
CAMBRIDGE
MA
02139
1
0
0
0
Common stock
2022-05-20
4
M
0
1585
0
A
117879
D
Common stock
79082
I
See footnote
Common stock
270772
I
See footnote
Restricted stock unit
2022-05-20
4
M
0
1585
0
D
Common stock
1585.0
0
D
Shares held by Amy P. Schenkein 2004 Revocable Trust, of which the reporting person's spouse is trustee and beneficiary.
Shares held by David P. Schenkein 2004 Revocable Trust, of which the reporting person is trustee and beneficiary.
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
There restricted stock units were granted on May 20, 2021. The shares underlying these restricted stock units vest as to 100% of the underlying shares on May 20, 2022.
/s/ William Cook, as Attorney in Fact for David Schenkein
2022-05-24